Mox-CV is a combination medicine containing the semisynthetic antibiotic Amoxycillin and the βlactamase inhibitor, Potassium clavulanate (βlactamase is a type of enzyme produced by bacteria that resists Amoxycillin action). Amoxycillin has a bactericidal effect. However, it is susceptible to hydrolysis by β-lactamases. Addition of clavulanic acid extends the antimicrobial spectrum and activity of amoxycillin. β-lactamase resistance is an increasing problem that results in treatment failure in many common infections. Augmentin first overcomes the β-lactamase resistance, then deals with the bacteria.
Mox-CV is indicated in various bacterial infections like, Skin and Skin Structure Infections, Urinary Tract Infections, Upper Respiratory Tract Infections.
Lower Respiratory Tract Infections. It is available in an injectable, tablet, dry syrup and drops form.
Mox-CV is a brand from Sun Pharma. Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.
The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anti-cancers, steroids, peptides, sex hormones, and controlled substances.